Ultrasound-guided botulinum toxin A injection: An alternative treatment for dribbling

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Dribbling (sialorrhoea) affects about 10 per cent of patients with chronic neurological disease. The variety of treatments currently available is unsatisfactory. This study was a clinical trial of the efficacy of ultrasound-guided, intraglandular injection of botulinum toxin A for dribbling, performed within the otorhinolaryngology department of the National University of Malaysia. Both pairs of parotid and submandibular glands received 25 U each of botulinum toxin A. Twenty patients were enrolled in the study. The median age was 15 years. All 20 patients (or their carers) reported a distinct improvement in symptoms after injection. Using the Wilcoxon signed rank test, there were significant reductions in dribbling rating score, dribbling frequency score, dribbling severity score, dribbling visual analogue score and towel changes score, comparing pre- and post-injection states (p<0.001). There were no complications or adverse effects during or after the injection procedure. Intraglandular, major salivary gland injection of botulinum toxin A is an effective treatment to reduce dribbling. Ultrasound guidance enhances the accuracy of this procedure and minimises the risk of complication.

Original languageEnglish
Pages (from-to)609-614
Number of pages6
JournalJournal of Laryngology and Otology
Volume122
Issue number6
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Type A Botulinum Toxins
Injections
Therapeutics
Sialorrhea
Submandibular Gland
Malaysia
Parotid Gland
Otolaryngology
Nonparametric Statistics
Salivary Glands
Caregivers
Chronic Disease
Clinical Trials

Keywords

  • Botulinum Toxin Type A
  • Injection
  • Salivary Gland
  • Sialorrhoea
  • Ultrasonography

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

@article{a64ffbe1466b4c19b0ad07a2dde6b046,
title = "Ultrasound-guided botulinum toxin A injection: An alternative treatment for dribbling",
abstract = "Dribbling (sialorrhoea) affects about 10 per cent of patients with chronic neurological disease. The variety of treatments currently available is unsatisfactory. This study was a clinical trial of the efficacy of ultrasound-guided, intraglandular injection of botulinum toxin A for dribbling, performed within the otorhinolaryngology department of the National University of Malaysia. Both pairs of parotid and submandibular glands received 25 U each of botulinum toxin A. Twenty patients were enrolled in the study. The median age was 15 years. All 20 patients (or their carers) reported a distinct improvement in symptoms after injection. Using the Wilcoxon signed rank test, there were significant reductions in dribbling rating score, dribbling frequency score, dribbling severity score, dribbling visual analogue score and towel changes score, comparing pre- and post-injection states (p<0.001). There were no complications or adverse effects during or after the injection procedure. Intraglandular, major salivary gland injection of botulinum toxin A is an effective treatment to reduce dribbling. Ultrasound guidance enhances the accuracy of this procedure and minimises the risk of complication.",
keywords = "Botulinum Toxin Type A, Injection, Salivary Gland, Sialorrhoea, Ultrasonography",
author = "{Mat Baki}, Marina and Mohamed, {Abdullah Sani} and {Abdul Hamid}, Hamzaini and Hamidon, {B. B.}",
year = "2008",
month = "6",
doi = "10.1017/S0022215107008730",
language = "English",
volume = "122",
pages = "609--614",
journal = "Journal of Laryngology and Otology",
issn = "0022-2151",
publisher = "Cambridge University Press",
number = "6",

}

TY - JOUR

T1 - Ultrasound-guided botulinum toxin A injection

T2 - An alternative treatment for dribbling

AU - Mat Baki, Marina

AU - Mohamed, Abdullah Sani

AU - Abdul Hamid, Hamzaini

AU - Hamidon, B. B.

PY - 2008/6

Y1 - 2008/6

N2 - Dribbling (sialorrhoea) affects about 10 per cent of patients with chronic neurological disease. The variety of treatments currently available is unsatisfactory. This study was a clinical trial of the efficacy of ultrasound-guided, intraglandular injection of botulinum toxin A for dribbling, performed within the otorhinolaryngology department of the National University of Malaysia. Both pairs of parotid and submandibular glands received 25 U each of botulinum toxin A. Twenty patients were enrolled in the study. The median age was 15 years. All 20 patients (or their carers) reported a distinct improvement in symptoms after injection. Using the Wilcoxon signed rank test, there were significant reductions in dribbling rating score, dribbling frequency score, dribbling severity score, dribbling visual analogue score and towel changes score, comparing pre- and post-injection states (p<0.001). There were no complications or adverse effects during or after the injection procedure. Intraglandular, major salivary gland injection of botulinum toxin A is an effective treatment to reduce dribbling. Ultrasound guidance enhances the accuracy of this procedure and minimises the risk of complication.

AB - Dribbling (sialorrhoea) affects about 10 per cent of patients with chronic neurological disease. The variety of treatments currently available is unsatisfactory. This study was a clinical trial of the efficacy of ultrasound-guided, intraglandular injection of botulinum toxin A for dribbling, performed within the otorhinolaryngology department of the National University of Malaysia. Both pairs of parotid and submandibular glands received 25 U each of botulinum toxin A. Twenty patients were enrolled in the study. The median age was 15 years. All 20 patients (or their carers) reported a distinct improvement in symptoms after injection. Using the Wilcoxon signed rank test, there were significant reductions in dribbling rating score, dribbling frequency score, dribbling severity score, dribbling visual analogue score and towel changes score, comparing pre- and post-injection states (p<0.001). There were no complications or adverse effects during or after the injection procedure. Intraglandular, major salivary gland injection of botulinum toxin A is an effective treatment to reduce dribbling. Ultrasound guidance enhances the accuracy of this procedure and minimises the risk of complication.

KW - Botulinum Toxin Type A

KW - Injection

KW - Salivary Gland

KW - Sialorrhoea

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=44449105457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449105457&partnerID=8YFLogxK

U2 - 10.1017/S0022215107008730

DO - 10.1017/S0022215107008730

M3 - Article

C2 - 17640435

AN - SCOPUS:44449105457

VL - 122

SP - 609

EP - 614

JO - Journal of Laryngology and Otology

JF - Journal of Laryngology and Otology

SN - 0022-2151

IS - 6

ER -